Logo image of ICHR

ICHOR HOLDINGS LTD (ICHR) Stock Fundamental Analysis

NASDAQ:ICHR - KYG4740B1059 - Common Stock

17.88 USD
-0.28 (-1.54%)
Last: 8/25/2025, 8:00:02 PM
18 USD
+0.12 (+0.67%)
After Hours: 8/25/2025, 8:00:02 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to ICHR. ICHR was compared to 110 industry peers in the Semiconductors & Semiconductor Equipment industry. ICHR has a bad profitability rating. Also its financial health evaluation is rather negative. ICHR has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year ICHR was profitable.
In the past year ICHR had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: ICHR reported negative net income in multiple years.
Each year in the past 5 years ICHR had a positive operating cash flow.
ICHR Yearly Net Income VS EBIT VS OCF VS FCFICHR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M 80M

1.2 Ratios

The Return On Assets of ICHR (-2.10%) is worse than 60.91% of its industry peers.
Looking at the Return On Equity, with a value of -2.98%, ICHR is in line with its industry, outperforming 40.91% of the companies in the same industry.
Industry RankSector Rank
ROA -2.1%
ROE -2.98%
ROIC N/A
ROA(3y)0.02%
ROA(5y)2.26%
ROE(3y)0.6%
ROE(5y)4.81%
ROIC(3y)N/A
ROIC(5y)N/A
ICHR Yearly ROA, ROE, ROICICHR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20

1.3 Margins

The Gross Margin of ICHR (11.89%) is worse than 87.27% of its industry peers.
In the last couple of years the Gross Margin of ICHR has declined.
The Profit Margin and Operating Margin are not available for ICHR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 11.89%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.35%
GM growth 5Y-2.65%
ICHR Yearly Profit, Operating, Gross MarginsICHR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15

3

2. Health

2.1 Basic Checks

ICHR does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ICHR has more shares outstanding
ICHR has more shares outstanding than it did 5 years ago.
The debt/assets ratio for ICHR has been reduced compared to a year ago.
ICHR Yearly Shares OutstandingICHR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
ICHR Yearly Total Debt VS Total AssetsICHR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

An Altman-Z score of 2.79 indicates that ICHR is not a great score, but indicates only limited risk for bankruptcy at the moment.
ICHR has a Altman-Z score (2.79) which is in line with its industry peers.
A Debt/Equity ratio of 0.17 indicates that ICHR is not too dependend on debt financing.
The Debt to Equity ratio of ICHR (0.17) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Altman-Z 2.79
ROIC/WACCN/A
WACC11.48%
ICHR Yearly LT Debt VS Equity VS FCFICHR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

ICHR has a Current Ratio of 3.22. This indicates that ICHR is financially healthy and has no problem in meeting its short term obligations.
ICHR's Current ratio of 3.22 is in line compared to the rest of the industry. ICHR outperforms 56.36% of its industry peers.
ICHR has a Quick Ratio of 1.32. This is a normal value and indicates that ICHR is financially healthy and should not expect problems in meeting its short term obligations.
ICHR's Quick ratio of 1.32 is on the low side compared to the rest of the industry. ICHR is outperformed by 80.91% of its industry peers.
Industry RankSector Rank
Current Ratio 3.22
Quick Ratio 1.32
ICHR Yearly Current Assets VS Current LiabilitesICHR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

6

3. Growth

3.1 Past

ICHR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 1266.67%, which is quite impressive.
Measured over the past years, ICHR shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -33.82% on average per year.
The Revenue has grown by 15.44% in the past year. This is quite good.
The Revenue has been growing slightly by 6.46% on average over the past years.
EPS 1Y (TTM)1266.67%
EPS 3Y-63.79%
EPS 5Y-33.82%
EPS Q2Q%-40%
Revenue 1Y (TTM)15.44%
Revenue growth 3Y-8.18%
Revenue growth 5Y6.46%
Sales Q2Q%18.23%

3.2 Future

Based on estimates for the next years, ICHR will show a very strong growth in Earnings Per Share. The EPS will grow by 73.13% on average per year.
ICHR is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.59% yearly.
EPS Next Y184.41%
EPS Next 2Y173.11%
EPS Next 3Y106.44%
EPS Next 5Y73.13%
Revenue Next Year12.47%
Revenue Next 2Y9.09%
Revenue Next 3Y8.94%
Revenue Next 5Y8.59%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ICHR Yearly Revenue VS EstimatesICHR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 200M 400M 600M 800M 1B
ICHR Yearly EPS VS EstimatesICHR Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1 2 3

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 51.09, the valuation of ICHR can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of ICHR is on the same level as its industry peers.
The average S&P500 Price/Earnings ratio is at 27.03. ICHR is valued rather expensively when compared to this.
The Price/Forward Earnings ratio is 14.98, which indicates a correct valuation of ICHR.
90.00% of the companies in the same industry are more expensive than ICHR, based on the Price/Forward Earnings ratio.
ICHR is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.63, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 51.09
Fwd PE 14.98
ICHR Price Earnings VS Forward Price EarningsICHR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ICHR is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 27.55
ICHR Per share dataICHR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20 25

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ICHR's earnings are expected to grow with 106.44% in the coming years.
PEG (NY)0.28
PEG (5Y)N/A
EPS Next 2Y173.11%
EPS Next 3Y106.44%

0

5. Dividend

5.1 Amount

No dividends for ICHR!.
Industry RankSector Rank
Dividend Yield N/A

ICHOR HOLDINGS LTD

NASDAQ:ICHR (8/25/2025, 8:00:02 PM)

After market: 18 +0.12 (+0.67%)

17.88

-0.28 (-1.54%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)08-04 2025-08-04/amc
Earnings (Next)11-03 2025-11-03/amc
Inst Owners99.16%
Inst Owner Change0.49%
Ins Owners2.07%
Ins Owner Change18.12%
Market Cap613.82M
Analysts80
Price Target24.65 (37.86%)
Short Float %4.67%
Short Ratio2.1
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-67.14%
Min EPS beat(2)-79.27%
Max EPS beat(2)-55.02%
EPS beat(4)1
Avg EPS beat(4)-33.43%
Min EPS beat(4)-79.27%
Max EPS beat(4)10.09%
EPS beat(8)2
Avg EPS beat(8)-597.61%
EPS beat(12)5
Avg EPS beat(12)-369.48%
EPS beat(16)6
Avg EPS beat(16)-277.99%
Revenue beat(2)1
Avg Revenue beat(2)-0.85%
Min Revenue beat(2)-2.16%
Max Revenue beat(2)0.45%
Revenue beat(4)2
Avg Revenue beat(4)-0.4%
Min Revenue beat(4)-2.16%
Max Revenue beat(4)1.83%
Revenue beat(8)5
Avg Revenue beat(8)-0.11%
Revenue beat(12)7
Avg Revenue beat(12)-0.07%
Revenue beat(16)8
Avg Revenue beat(16)-0.38%
PT rev (1m)-20.33%
PT rev (3m)-27.14%
EPS NQ rev (1m)-45.86%
EPS NQ rev (3m)-65.5%
EPS NY rev (1m)-41.77%
EPS NY rev (3m)-41.77%
Revenue NQ rev (1m)0.18%
Revenue NQ rev (3m)-6.06%
Revenue NY rev (1m)0.4%
Revenue NY rev (3m)0.4%
Valuation
Industry RankSector Rank
PE 51.09
Fwd PE 14.98
P/S 0.66
P/FCF N/A
P/OCF 35.99
P/B 0.88
P/tB 1.95
EV/EBITDA 27.55
EPS(TTM)0.35
EY1.96%
EPS(NY)1.19
Fwd EY6.67%
FCF(TTM)-0.55
FCFYN/A
OCF(TTM)0.5
OCFY2.78%
SpS27.07
BVpS20.22
TBVpS9.15
PEG (NY)0.28
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.1%
ROE -2.98%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 11.89%
FCFM N/A
ROA(3y)0.02%
ROA(5y)2.26%
ROE(3y)0.6%
ROE(5y)4.81%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.35%
GM growth 5Y-2.65%
F-Score6
Asset Turnover0.94
Health
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Debt/EBITDA 5.01
Cap/Depr 115.9%
Cap/Sales 3.88%
Interest Coverage N/A
Cash Conversion 72.65%
Profit Quality N/A
Current Ratio 3.22
Quick Ratio 1.32
Altman-Z 2.79
F-Score6
WACC11.48%
ROIC/WACCN/A
Cap/Depr(3y)62.01%
Cap/Depr(5y)61.74%
Cap/Sales(3y)2.1%
Cap/Sales(5y)1.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1266.67%
EPS 3Y-63.79%
EPS 5Y-33.82%
EPS Q2Q%-40%
EPS Next Y184.41%
EPS Next 2Y173.11%
EPS Next 3Y106.44%
EPS Next 5Y73.13%
Revenue 1Y (TTM)15.44%
Revenue growth 3Y-8.18%
Revenue growth 5Y6.46%
Sales Q2Q%18.23%
Revenue Next Year12.47%
Revenue Next 2Y9.09%
Revenue Next 3Y8.94%
Revenue Next 5Y8.59%
EBIT growth 1Y59.23%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year255.23%
EBIT Next 3Y56.45%
EBIT Next 5Y48.64%
FCF growth 1Y-139.16%
FCF growth 3YN/A
FCF growth 5Y-22.51%
OCF growth 1Y-77.09%
OCF growth 3Y22.22%
OCF growth 5Y-13.37%